Tag: advogains

August 2023: During data collection came across one person who had stopped taking ARV since February 2018. She mentioned that she couldn’t afford the monitoring test at private laboratory and during that point of time the staff at ART center would ask for test reports from private laboratory exclusively and that lead to lost to […]

During August, data enumerators met 14 individuals who completed HCV treatment but have not done their SVR test to check for cure due to lack of treatment education or relapse of drug use. Action taken: Explained the importance of SVR test and to check if the treatment has effectively responded or not. All 14 individuals […]

August 24th 2023: Enumerator reported a stock-out of DAA in Sanglah Hospital, Bali on August 24th. Same day Peduli Hati communicated with Hepatitis Program Officer at the Provincial Health Office. 30th of August: Provincial Health Office communicated to Peduli Hati that Sofosbuvir and Daclatasvir is now available at their warehouse and ready to be distributed […]

In April, a patient who was identified during the data collection process with advanced cirrhosis had extreme difficulty initiating and continuing his hepatitis C treatment facility, which was JNIMS in Imphal. Action Taken: In April, after speaking and meeting with the patient’s treatment center, he was transferred to a health facility at Thoubal district where he […]

During April to June survey period, the interviewer team met a number of people who inject drugs who had already completed their treatment for hepatitis C, but had not undergone virus testing to confirm sustained virologic response (SVR). Action Taken: In between the April to June, 6 people who inject drugs use were successfully referred for […]

In June 2023, while conducting a CLM interview, an interviewer met a teenager who had been abandoned by her father after she was born, and was being raised by her mother. Both mother and daughter had been self-reliant, but her mother became unemployed and unable to support their needs. She sought financial assistance from the […]

In July 2023, interviewers met a woman living with HIV who was on 2nd-line antiretroviral therapy, but was having to use the pediatric formulation of lopinavir/ritonavir due to stock-outs of the adult formulation. This required her to take multiple pills and she became uncertain over the reliability of the medicines. Action Taken: After a phone conversation […]

In March 2023, CLM team members met a woman living with HIV in a sero-discordant relationship. After living together for about 4 years, her husband started abusing her mentally and physically due to her HIV positive status. She was disowned by her husband and forced out of her home, but was not granted a legal […]

On 29 May 2023, Peduli Hati, the Director General of Pharmaceutical and Medical Devices, and representatives of the Communication and Public Service Bureau and the Indonesian CDC discussed procurement of additional hepatitis C medicines and rapid molecular testing machines using the national Global Fund budget. Action taken: By July 2023, there was an agreement to procure […]

After a protest rally on 29 May 2023 on the need to create access to hepatitis C treatment, the government procured daclatasvir through an emergency purchase mechanism the next day on 30 May 2023. Action taken: On 31 May 2023 the Hepatitis Working Team, Peduli Hati and the Provincial Health Office conducted a coordination meeting […]